Home | Site Map | Contact Us
NYRx, the Medicaid Pharmacy Program
Single Statewide Medication Assisted Treatment (MAT) Formulary
Single Statewide Medication Assisted Treatment (MAT) Formulary
The New York State Executive Budget for State Fiscal Year 2020-2021, in accordance to § 367-a (7) (e) of Social Services Law, enacts a statewide formulary for Opioid Antagonists and Opioid Dependence Agents for Medicaid Managed Care (MC) Plans and Medicaid Fee for Service (FFS) Program. Under this statewide formulary (link provided below), Medicaid MC and FFS members will follow a single formulary and coverage parameters are consistent across the Medicaid Program.
On December 22, 2021, Governor Hochul signed Chapter 720 of the Laws of 2021. This law amends Social Services Law and the Public Health Law, in relation to medication for the treatment of substance use disorders. Effective March 22, 2022, prior authorization will not be required for medications used for the treatment of substance use disorder when prescribed according to generally accepted national professional guidelines for the treatment of a substance use disorder.
MAT Statewide Formulary - List of Medication Assisted Treatment Agents
Additional Information:
- Legislation - Social Services Law TITLE 11; 367-A SECTION 7, Social Services Law TITLE 11; 364-J, Public Health Law TITLE 1; 273
- Statewide Formulary for Opioid Dependence Agents and Opioid Antagonists - Effective March 22, 2022
- Statewide Formulary for Opioid Dependence Agents and Opioid Antagonists - Effective October 1, 2021 - New Information
- Statewide Formulary for Opioid Dependence Agents and Opioid Antagonists - Effective October 1, 2021